Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Thomas Powles
,
Mark Kockx
,
Alejo Rodriguez-Vida
,
Ignacio Duran
,
Simon J Crabb
,
Michiel S Van Der Heijden
,
Bernadett Szabados
,
Albert Font Pous
,
Gwenaelle Gravis
,
Urbano Anido Herranz
,
Andrew Protheroe
,
Alain Ravaud
,
Denis Maillet
,
Maria Jose Mendez
,
Cristina Suarez
,
Mark Linch
,
Aaron Prendergast
,
Pieter-Jan van Dam
,
Diana Stanoeva
,
Sofie Daelemans
,
Sanjeev Mariathasan
,
Joy S Tea
,
Kelly Mousa
,
Romain Banchereau
,
Daniel Castellano
More about this publication
Nature medicine
Volume
29
Issue nr.
12
Pages
3271
Publication date
01-12-2023
Full text links
Publisher website (DOI)
10.1038/s41591-023-02312-9
Europe PubMed Central
36944799
Pubmed
36944799